References
- LipinskiCALombardoFDominyBWFeeneyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdv Drug Deliv Rev2001461–332611259830
- FahrALiuXDrug delivery strategies for poorly water-soluble drugsExpert Opin Drug Deliv20074440341617683253
- DressmanJChristosRDrug solubility: how to measure it, how to improve itAdv Drug Del Rev2007597531532
- Merisko-LiversidgeELiversidgeGGCooperERNanosizing: a formulation approach for poorly-water-soluble compoundsEur J Pharm Sci200318211312012594003
- MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
- HaussDJOral lipid-based formulationsAdv Drug Deliv Rev200759766767617618704
- ColeETCadéDBenameurHChallenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administrationAdv Drug Deliv Rev200860674775618096270
- LeunerCDressmanJImproving drug solubility for oral delivery using solid dispersionsEur J Pharm Biopharm2000501476010840192
- VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today20071223–241068107518061887
- SharmaSSherPBadveSPawarAPAdsorption of meloxicam on porous calcium silicate: characterization and tablet formulationAAPS PharmSciTech200564E618E62516408863
- FriedrichHFussneggerBKolterKBodmeierRDissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriersEur J Pharm Biopharm200662217117716275049
- SanganwarGPGuptaRBDissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxideInt J Pharm20083601–221321818550302
- KinoshitaMBabaKNagayasuAImprovement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicateJ Pharm Sci200291236237011835196
- SmirnovaIMamicJArltWAdsorption of drugs on silica aerogelsLangmuir2003192085218525
- TanASimovicSDaveyAKRadesTPrestidgeCASilica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugsJ Control Release20091341627019013488
- BahlDBognerRHAmorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanismPharm Res200623102317232516927179
- SmirnovaISuttiruengwongSSeilerMArltWDissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogelsPharm Dev Technol20049444345215581080
- Quintanar-GuerreroDGanem-QuintanarANava-ArzaluzMGPiñón-SegundoESilica xerogels as pharmaceutical drug carriersExpert Opin Drug Deliv20096548549819413456
- SlowingIIVivero-EscotoJLWuCWLinVSMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Deliv Rev200860111278128818514969
- ColillaMManzanoMVallet-RegíMRecent advances in ceramic implants as drug delivery systems for biomedical applicationsInt J Nanomedicine20083440341419337409
- KresgeCLeonowiczMRothWVartuliJBeckJOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanismNature19923596397710712
- ChenBWangZQuanGIn vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulationInt J Nanomedicine2012719920922275835
- Vallet-RegíMBalasFColillaMManzanoMDrug confinement and delivery in ceramic implantsDrug Metab Lett200711374019356016
- HeikkiläTSalonenJTuuraJMesoporous silica material TUD-1 as a drug delivery systemInt J Pharm2007331113313817046183
- Vallet-RegíMDoadrioJCDoadrioALIzquierdo-BarbaIPérez-ParienteJHexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillinSolid State Ionics20041721–4435439
- HollandBTBlanfordCFSteinASynthesis of macroporous minerals with highly ordered three-dimensional arrays of spheroidal voidsScience199828153765385409677191
- LytleJCYanHErgangNSSmyrlWHSteinAStructural and electrochemical properties of three-dimensionally ordered macroporous tin(IV) oxide filmsJ Mater Chem20041416161622
- LeeKLytleJErgangNOhSSteinASynthesis and rate performance of monolithic macroporous carbon electrodes for lithium-ion secondary batteriesAdv Funct Mater2005154547556
- VelevODLenhoffAMColloidal crystals as templates for porous materialsCurr Opin Colloid In200051–25663
- SteinASchrodenRCColloidal crystal templating of three-dimensionally ordered macroporous solids: materials for photonics and beyondCurr Opin Solid St Mater Sci200156553564
- HancockBCDisordered drug delivery: destiny, dynamics and the Deborah numberJ Pharm Pharmacol200254673774612078989
- YoshiokaMHancockBCZografiGCrystallization of indomethacin from the amorphous state below and above its glass transition temperatureJ Pharm Sci19948312170017057891297
- WilliamsACTimminsPLuMForbesRTDisorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymersEur J Pharm Sci2005263–428829416087323
- TangFLiLChenDMesoporous silica nanoparticles: synthesis, biocompatibility and drug deliveryAdv Mater Weinheim201224121504153422378538
- FuCLiuTLiLLiuHChenDTangFThe absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routesBiomaterials201334102565257523332175
- GuzmánELiggieriLSantiniEInfluence of silica nanoparticles on dilational rheology of DPPC–palmitic acid Langmuir monolayersSoft Matter2012839383948
- HeikkiläTSantosHAKumarNCytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cellsEur J Pharm Biopharm201074348349420025968
- Di PasquaAJSharmaKKShiYLCytotoxicity of mesoporous silica nanomaterialsJ Inorg Biochem200810271416142318279965
- LeeSYunHSKimSHThe comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosisBiomaterials201132359434944321889200
- WangFHuiHBarnesTJBarnettCPrestidgeCAOxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugsMol Pharm20107122723619874003
- HuYWangJZhiZJiangTWangSFacile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drugJ Colloid Interface Sci2011363141041721820127
- CaiQLinWYXiaoFSPangWQChenXHZouBSThe preparation of highly ordered MCM-41 with extremely low surfactant concentrationMicropor Mesopor Mater1999321–2115
- ZhaoDFengJHuoQTriblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom poresScience199827953505485529438845
- ZhangJJinYLiCCreation of three-dimensionally ordered macroporous Au/CeO2 catalysts with controlled pore sizes and their enhanced catalytic performance for formaldehyde oxidationAppl Catal B: Environmental2009911–21120
- HuYZhiZWangTJiangTWangSIncorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancyEur J Pharm Biopharm201179354455121767643
- Barzegar-JalaliMMalekiNGarjaniAEnhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition techniqueDrug Dev Ind Pharm200228668168612149960
- HuYZhiZZhaoQ3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilolMicropor Mesopor Mater2012147194101
- SingKEverettDHaulRReporting physisorption data for gas/solid systems - with special reference to the determination of surface area and porosityPure Appl Chem1985574603619
- MellaertsRMolsRJammaerJAIncreasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaEur J Pharm Biopharm200869122323018164930
- JiCBarrettAPoole-WarrenLAFosterNRDehghaniFThe development of a dense gas solvent exchange process for the impregnation of pharmaceuticals into porous chitosanInt J Pharm20103911–218719620214968
- MadiehSSimoneMWilsonWMehraDAugsburgerLInvestigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbentsJ Pharm Sci200796485186317221849
- BlagdenNde MatasMGavanPTYorkPCrystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdv Drug Deliv Rev200759761763017597252
- HancockBCParksMWhat is the true solubility advantage for amorphous pharmaceuticals?Pharm Res200017439740410870982
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
- LiYSunLJinMSize-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cellsToxicol In Vitro20112571343135221575712
- Di PasquaAJSharmaKKShiYLCytotoxicity of mesoporous silica nanomaterialsJ Inorg Biochem200810271416142318279965